285 References 18. Detterbeck FC. The eighth edition TNM stage classification for lung cancer: What does it mean on main street? J Thorac Cardiovasc Surg. 2018;155(1):356-359. doi:10.1016/j. jtcvs.2017.08.138 19. Borczuk AC, Cooper WA, Dacic S, et al. Tumours of the lung. In: WHO_Editorial_Board, ed. WHO Classification of Tumours Editorial Board. Thoracic Tumours. Lyon (France): International Agency for Research on Cancer; 2021. (WHO Classification of Tumours Series, 5th Ed.; Vol. 5). 5th ed. IARC; 2021:19-189. 20. Chansky K, Sculier JP, Crowley JJ, Giroux D, Meerbeeck J Van, Goldstraw P. The international association for the study of lung cancer staging project: Prognostic factors and pathologic TNM stage in surgically managed non-small cell lung cancer. J Thorac Oncol. 2009;4(7):792-801. doi:10.1097/JTO.0b013e3181a7716e 21. Takeda S ichi, Maeda H, Okada T, et al. Results of pulmonary resection following neoadjuvant therapy for locally advanced (IIIA-IIIB) lung cancer. Eur J Cardio-thoracic Surg. 2006;30(1):184-189. doi:10.1016/j.ejcts.2006.03.054 22. Caglar HB, Baldini EH, Othus M, et al. Outcomes of patients with stage III nonsmall cell lung cancer treated with chemotherapy and radiation with and without surgery. Cancer. 2009;115(18):4156-4166. doi:10.1002/cncr.24492 23. Kappers I, van Sandick JW, Burgers JA, et al. Results of combined modality treatment in patients with non-small-cell lung cancer of the superior sulcus and the rationale for surgical resection. Eur J Cardio-thoracic Surg. 2009;36(4):741-746. doi:10.1016/j.ejcts.2009.04.069 24. Peedell C, Dunning J, Bapusamy a. Is there a standard of care for the radical management of non-small cell lung cancer involving the apical chest wall (Pancoast tumours)? Clin Oncol (R Coll Radiol). 2010;22(5):334-346. doi:10.1016/j.clon.2010.03.001 25. Pourel N, Santelmo N, Naafa N, et al. Concurrent cisplatin/etoposide plus 3D-conformal radiotherapy followed by surgery for stage IIB (superior sulcus T3N0)/III non-small cell lung cancer yields a high rate of pathological complete response. Eur J Cardiothorac Surg. 2008;33(5):829-836. doi:10.1016/j.ejcts.2008.01.063 26. Rusch VW, Giroux DJ, Kraut MJ, et al. Induction chemoradiation and surgical resection for superior sulcus non-small-cell lung carcinomas: long-term results of Southwest Oncology Group Trial 9416 (Intergroup Trial 0160). J Clin Oncol. 2007;25(3):313-318. doi:10.1200/ JCO.2006.08.2826 27. Junker K, Thomas M, Schulmann K, Klinke F, Bosse U, M ller KM. Tumour regression in nonsmall-cell lung cancer following neoadjuvant therapy. Histological assessment. J Cancer Res Clin Oncol. 1997;123(9):469-477. http://www.ncbi.nlm.nih.gov/pubmed/9341895 28. Liu-Jarin X, Stoopler MB, Raftopoulos H, Ginsburg M, Gorenstein L, Borczuk AC. Histologic Assessment of Non-Small Cell Lung Carcinoma after Neoadjuvant Therapy. Mod Pathol. 2003;16(11):1102-1108. doi:10.1097/01.MP.0000096041.13859.AB 29. Yamane Y, Ishii G, Goto K, et al. A novel histopathological evaluation method predicting the outcome of non-small cell lung cancer treated by neoadjuvant therapy: The prognostic importance of the area of residual tumor. J Thorac Oncol. 2010;5(1):49-55. doi:10.1097/ JTO.0b013e3181c0a1f8 30. Detterbeck FC. Changes in the treatment of Pancoast tumors. Ann Thorac Surg. 2003;75(6):1990-1997. doi:10.1016/S0003-4975(03)00134-6 31. Eisenhauer EA, Therasse P, Bogaerts J, et al. New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1). Eur J Cancer. 2009;45(2):228-247. doi:10.1016/j.ejca.2008.10.026 32. Brambilla E, Travis WD, Colby T V., Corrin B, Shimosato Y. The new World Health Organization classification of lung tumours. Eur Respir J. 2001;18(6):1059-1068. doi:10.1183/09031936 .01.00275301 33. Dworak O, Keilholz L, Hoffmann A. Pathological features of rectal cancer after preoperative radiochemotherapy. Int J Colorectal Dis. 1997;12(1):19-23. doi:10.1007/s003840050072 A
RkJQdWJsaXNoZXIy MTk4NDMw